These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 328020)

  • 1. [On the enteral absorption of valproic acid (author's transl)].
    Oelkers W; Stoffels G; Schäfer H; Reith H
    Arzneimittelforschung; 1977; 27(5):1088-90. PubMed ID: 328020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on the urinary excretion of metabolites of valproic acid (dipropylacetic acid) in rats and humans (author's transl)].
    Kochen W; Imbeck H; Jakobs C
    Arzneimittelforschung; 1977; 27(5):1090-9. PubMed ID: 328021
    [No Abstract]   [Full Text] [Related]  

  • 3. Relative bioavailability of different valproic acid formulations.
    Franke G; Diletti E; Hoffmann C; Zschiesche M; Scheuch E; Siegmund W
    Int J Clin Pharmacol Ther; 1995 Dec; 33(12):653-7. PubMed ID: 8963482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of valproic acid after administration of three oral formulations in healthy adults.
    Bano G; Gupta S; Gupta KL; Raina RK
    J Assoc Physicians India; 1990 Sep; 38(9):629-30. PubMed ID: 2266076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bioavailability of a valproic acid preparation. The relative bioavailability of enteric-resistant valproic acid preparations in tablet form with simultaneously administered tetradeuterated valproic acid as the bioavailability reference].
    Hoffmann F; Jancik BC; von Unruh GE
    Arzneimittelforschung; 1986 Jul; 36(7):1118-22. PubMed ID: 3094548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and bioavailability of sodium valproate.
    Klotz U; Antonin KH
    Clin Pharmacol Ther; 1977 Jun; 21(6):736-43. PubMed ID: 324695
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacokinetic study of sodium di-n-propylacetate (usual tablet and enteric coated tablet with delayed absorption) (author's transl)].
    van de Mortel I; franck G
    Acta Neurol Belg; 1976; 76(3):165-72. PubMed ID: 788439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid in epilepsy: clinical and pharmacological effects.
    Mattson RH; Cramer JA; Williamson PD; Novelly RA
    Ann Neurol; 1978 Jan; 3(1):20-5. PubMed ID: 350128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of valproic acid obtained after administration of three oral formulations to humans.
    Bialer M; Hussein Z; Dubrovsky J; Raz I; Abramsky O
    Isr J Med Sci; 1984 Jan; 20(1):46-9. PubMed ID: 6421770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of food on valproic acid absorption.
    Hamilton RA; Garnett WR; Kline BJ; Pellock JM
    Am J Hosp Pharm; 1981 Oct; 38(10):1490-3. PubMed ID: 6794365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The bioavailability of nifedipine in different solid pharmaceutical preparations for oral use].
    Leucuta SE; Vida-Simiti L; Mocan A; Făgărăşan E; Bugnariu S; Baloescu C; Olinic N; Vlaicu R
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(6):521-8. PubMed ID: 2577014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
    Wangemann M; Retzow A; Vens-Cappell B
    Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study of serum level of dipropylacetic acid sodium (Depakene) by gaschromatography (author's transl)].
    Hosokawa K; Kugoh T; Otsuki S
    No To Shinkei; 1977 Aug; 29(8):885-90. PubMed ID: 409421
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of enteric-coated valproic acid.
    Albright PS; Bruni J; Suria D
    Ther Drug Monit; 1984; 6(1):21-3. PubMed ID: 6424275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of valproic acid in patients with liver disease.
    Klotz U; Rapp T; Müller WA
    Eur J Clin Pharmacol; 1978 Mar; 13(1):55-60. PubMed ID: 346355
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bioavailability of sodium valproate is modified by diet].
    Loiseau P; Cenraud B; Morselli PL; Brachet-Liermain A
    Nouv Presse Med; 1979 Jun; 8(26):2202-3. PubMed ID: 382109
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased dipropylacetic acid bioavailability from dipropylacetamide by food.
    Pisani F; D'Agostino AA; Fazio A; Oteri G; Primerano G; Di Perri R
    Epilepsia; 1982 Apr; 23(2):115-21. PubMed ID: 6804222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is sodium valproate bioavailability only altered by food intake?].
    Bruguerolle B; Valli M; Jadot G; Bouyard L; Bouyard P
    Nouv Presse Med; 1980 Jan; 9(1):44. PubMed ID: 6766550
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical pharmacological aspects of valproate sodium.
    Wulff K; Flachs H; Würtz-Jorgensen A; Gram L
    Epilepsia; 1977 Jun; 18(2):149-57. PubMed ID: 326543
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on the pharmacokinetic equivalence of pivampicillin base and hydrochloride in capsules and tablets (author's transl)].
    Fedorcak V; Mielenz H; Bozler G
    Arzneimittelforschung; 1977; 27(3):659-65. PubMed ID: 577441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.